Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

Sadia Zafar, Dafne Carolina Alves Quixabeira, Tatiana Viktorovna Kudling, Victor Cervera-Carrascon, Joao Manuel Santos, Susanna Grönberg-Vähä-Koskela, Fang Zhao, Pasi Aronen, Camilla Heiniö, Riikka Havunen, Suvi Sorsa, Anna Kanerva, Akseli Hemminki

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalCancer Gene Therapy
Number of pages13
ISSN0929-1903
DOIs
Publication statusE-pub ahead of print - 12 Sep 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • PHASE-I TRIAL
  • ONCOLYTIC ADENOVIRUS
  • CANCER-PATIENTS
  • GENE-TRANSFER
  • CLINICAL-TRIAL
  • OVARIAN-CANCER
  • DESMOGLEIN 2
  • VIRUS
  • RECEPTOR
  • FIBER

Cite this